Randomized Controlled Trial to Decrease Admission Rates in Medically Complex Children in a Medical Home Program
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Chronic Illness
- Sponsor
- University of California, Los Angeles
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- (2) preventable admissions, defined by 2 independent physicians blinded to study assignment as an admission due primarily to one of the preventable factors identified from Phase 1 of the study
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The investigators hypothesize that an intervention, within an established patient-centered medical home, aimed at reducing modifiable risks for hospitalization, can decrease hospital utilization among medically complex children.
Detailed Description
The investigators will pilot test an intervention that includes contingency planning and care transitions within an established medical home program caring for children with medical complexity. Children with medical complexity receiving care within the UCLA Medical Home Program will be randomized to the pilot intervention or usual medical home care. The primary goal will be to reduce admissions and readmissions in the intervention group.
Investigators
Thomas Klitzner, MD, PhD
Executive Directior, Pediatric Medical Home Program at UCLA
University of California, Los Angeles
Eligibility Criteria
Inclusion Criteria
- •Children ages 0 to 17 years old who are enrolled in the Pediatric Medical Home Program at UCLA
- •English and Spanish-speaking only
Exclusion Criteria
- •Children older than 17 years old who are enrolled in the Pediatric Medical Home Program
- •Non-English and Non-Spanish speakers
Outcomes
Primary Outcomes
(2) preventable admissions, defined by 2 independent physicians blinded to study assignment as an admission due primarily to one of the preventable factors identified from Phase 1 of the study
Time Frame: 18 to 24 months
(1) number of all-cause admissions, defined as any admission occurring during the study period
Time Frame: 18 to 24 months